Physician profile
Samuel Wang
NPI 1013931039
$4,998.80
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,002 · 2020: $798 · 2021: $427 · 2022: $565 · 2023: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,419.05 | 2019-2020 | |
| Boston Scientific Corporation | $759.61 | 2019-2023 | Watchman Access System, Accolade Sr, Watchman Flx |
| Amgen INC. | $269.35 | 2019 | |
| Janssen Pharmaceuticals, INC | $250.80 | 2019 | |
| Abiomed | $172.67 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $155.11 | 2019-2020 | |
| Biosense Webster, INC. | $136.27 | 2020-2022 | |
| Bardy Diagnostics, INC. | $101.17 | 2021-2022 | |
| Abbott Laboratories | $98.68 | 2019-2023 | Ensite Precision |
| Novartis Pharmaceuticals Corporation | $91.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $69.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $67.94 | 2019 | |
| Chiesi USA, INC. | $64.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.33 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.33 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $54.38 | 2019 | |
| Irhythm Technologies, INC. | $43.26 | 2019-2020 | |
| Pfizer INC. | $35.41 | 2019 | |
| Alnylam Pharmaceuticals INC. | $29.87 | 2019 | |
| Astellas Pharma US INC | $24.11 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $23.03 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.